June 2026
M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Maxime Dely: Venous Access in Apheresis Technology Isn’t Everything

Maxime Dely/LinkedIn

Apr 24, 2026, 16:06

Maxime Dely: Venous Access in Apheresis Technology Isn’t Everything

Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:

”Venous access in apheresis technology isn’t everything

In apheresis, the objective is clear: collect blood, process it, and isolate either harmful elements or useful components such as specific lymphocyte subsets

But behind this technical process lies a very concrete reality: venous access

Without a usable vein, there is no apheresis. And depending on the patient’s condition – disease, malnutrition, or vascular fragility – access can be a real challenge

Another key factor is flow rate. It must be sufficient to feed the centrifuge, but it also directly impacts the duration of the procedure and therefore the patient’s comfort

Solutions exist such as vascular mapping, Doppler, and ultrasound. But they don’t replace what matters most

Nursing expertise

Their experience often makes all the difference where technology alone falls short

Because beyond the machines, there is an essential human factor

What role do you think hands-on expertise should play alongside technology?”

Maxime Dely: Venous Access in Apheresis Technology Isn’t Everything